Vikram Karnani is President and Chief Executive Officer of Collegium Pharmaceutical, Inc (COLL). The company reported total compensation of $1,715,846 for fiscal year 2025.
| Salary | $875,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $0 |
| Non-equity incentive plan | $835,406 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $5,440 |
| Total | $1,715,846 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Collegium Pharmaceutical, Inc filed April 7, 2026, accession 0001628280-26-024063.
| Peer-group chief executive median | $8,418,147 |
|---|---|
| Difference from that median | $-6,702,300 |
| Percentile within the disclosed peer group | 1st |
| Peers with a disclosed figure | 6 |
Medians and percentiles are computed across the peer group Collegium Pharmaceutical, Inc discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| David Dieter | Executive Vice President and General Counsel | $3,870,092 |
| Colleen Tupper | Executive Vice President and Chief Financial Officer | $3,515,055 |
| Scott Dreyer | Executive Vice President and Chief Commercial Officer | $3,041,212 |
| Shirley Kuhlmann | Former Executive Vice President, Chief Administrative Officer, General Counsel and Secretary | $2,783,583 |
| Thomas Smith | Executive Vice President and Chief Medical Officer | $2,446,008 |
| Vikram Karnani this page | President and Chief Executive Officer | $1,715,846 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Collegium Pharmaceutical, Inc compensation brief.
Vikram Karnani's compensation sits inside Collegium Pharmaceutical, Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.